Related Experiment Video For Depression
Updated: Mar 23, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
Does mineralocorticoid receptor play a vital role in the development of depressive disorder?
Jiao Chen1, Zhen-Zhen Wang1, Shuai Zhang1
1State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica & Neuroscience Center, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
Abstract:
Depression is a leading cause of disability worldwide. However, the biological and molecular mechanisms underlying this disease remain unclear. Stress, a disposing factor in the development of depression, leads to hypothalamic-pituitary-adrenal (HPA) axis activation and glucocorticoids release. Glucocorticoids at physiological concentrations activate two types of steroid receptors including the glucocorticoid receptor (GR) and mineralocorticoid receptor (MR). During the past decades, lots of studies have confirmed the role of GR in depression. An increasing number of studies, in recent years, indicate that abnormal function of MR is also a crucial component of the pathophysiology of depression. Thus, this review summarizes the role of MR in the HPA axis dysregulation, inflammation, decreased neurogenesis and stress-related behaviors in depression. All of which will provide more information about MR in depression.
More Related Videos
Related Concept Videos
G-protein Coupled Receptors
Antidepressant Drugs: MAOIs and Other Agents
Depression: Overview
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Antidepressant Drugs: Overview
Depressive Disorders: MDD and Dysthymia

